TY - JOUR
T1 - Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
AU - Toussaint, Laura
AU - Brandal, Petter
AU - Embring, Anna
AU - Engellau, Jacob
AU - Evensen, Morten Egeberg
AU - Griskeviskius, Romualdas
AU - Hansen, Jolanta
AU - Hietala, Henna
AU - Wickart Johansson, Gun
AU - Jørgensen, Morten
AU - Kramer, Paul Heinz
AU - Kristensen, Ingrid
AU - Lehtio, Kaisa
AU - Magelssen, Henriette
AU - Maraldo, Maja Vestmø
AU - Marienhagen, Kirsten
AU - Martinsson, Ulla
AU - Nilsson, Kristina
AU - Peters, Sarah
AU - Plaude, Sandija
AU - Seiersen, Klaus
AU - Sendiuliene, Daiva
AU - Smulders, Bob
AU - Edvardsen, Tone
AU - Søbstad, Johan Martin
AU - Taheri, Zarah
AU - Vaalavirta, Leila
AU - Vestergaard, Anne
AU - Timmermann, Beate
AU - Lassen-Ramshad, Yasmin
AU - NOPHO Radiotherapy Working Group
PY - 2022
Y1 - 2022
N2 - Postoperative radiotherapy for intracranial paediatric ependymoma is challenging both for target definition and treatment planning [1]. Delineation of the tumour bed is difficult, as structures in prior contact with the tumour will shift back into their original positions after surgery. In infratentorial cases, the target is adjacent to the brainstem and upper spinal cord, therefore the relatively high prescription dose and sparing of surrounding organs at risk (OARs) need to be balanced. Through the radiotherapy working-group of the Nordic Organization of Pediatric Hematology and Oncology (NOPHO) and in collaboration with the Westdeutsches Protonentherapizentrum Essen (WPE), a study was performed to quantify inter-centre variations in target delineation and treatment plans for these tumours.
AB - Postoperative radiotherapy for intracranial paediatric ependymoma is challenging both for target definition and treatment planning [1]. Delineation of the tumour bed is difficult, as structures in prior contact with the tumour will shift back into their original positions after surgery. In infratentorial cases, the target is adjacent to the brainstem and upper spinal cord, therefore the relatively high prescription dose and sparing of surrounding organs at risk (OARs) need to be balanced. Through the radiotherapy working-group of the Nordic Organization of Pediatric Hematology and Oncology (NOPHO) and in collaboration with the Westdeutsches Protonentherapizentrum Essen (WPE), a study was performed to quantify inter-centre variations in target delineation and treatment plans for these tumours.
U2 - 10.1080/0284186X.2021.2022202
DO - 10.1080/0284186X.2021.2022202
M3 - Letter
C2 - 34970940
AN - SCOPUS:85122663205
SN - 0284-186X
VL - 61
SP - 235
EP - 238
JO - Acta Oncologica
JF - Acta Oncologica
IS - 2
ER -